What is LOPJLB’s current signal on IMRX?

LOPJLB’s latest quantitative signal on Immuneering Corporation (IMRX) is BUY in a RECOVERY regime. Signals are updated daily.

What market regime is IMRX in?

Immuneering Corporation (IMRX) is currently classified in the RECOVERY HMM market regime on LOPJLB.

What does Immuneering Corporation (IMRX) do?

Immuneering Corporation is a biopharmaceutical company dedicated to developing novel therapeutic candidates in the fields of oncology (cancer) and neuroscience. Leading its clinical development efforts are two key drug candidates: IMM-1-104, a dual-MEK inhibitor intended for the treatment of various cancers, including pancreatic, melanoma, colorectal, and non-small cell lung cancer, specificall…

Where is Immuneering Corporation based / listed?

Immuneering Corporation is based in US, listed on NASDAQ.

Immuneering Corporation (IMRX) Stock · BUY · RECOVERY

Key stats

Short interest · FINRA settlement 2026-07-31

Market cap: $188M
Avg volume: 1.3M
Beta: 0.37
P/E (TTM): -4.98

Short % float: 61.05%
Days to cover: 20.4
SI change: +1.3%

1W: -0.77%
1M: +19.91%
3M: -3.90%
YTD: -21.75%

vs SPY 1W: +0.42%
vs SPY 1M: +16.59%
vs SPY 3M: -6.29%
vs SPY YTD: -33.51%

Sector peers

Same-sector names ranked by LOPJLB quality proximity · Healthcare

Industry peers

FMP comparable companies · ranked by market cap

Prediction markets

Kalshi · Polymarket · … linked

Full prediction markets →

Loading markets…

Immuneering Corporation (IMRX)

Key stats

Sector peers

Industry peers

Prediction markets

ANALYST & RATINGS

Company news